- Doctors & Departments
- Conditions & Advice
- Your Visit
- Research & Innovation
Twin reversed arterial perfusion sequence, or TRAP sequence, is a rare complication affecting identical twins. In approximately 1 in 35,000 births, an abnormal twin that may have an absent or abnormal heart, develops and receives blood flow directly from a normally developed twin or what is called a "pump" twin. Because the pump twin's heart must supply blood for itself as well as for the abnormal twin, it may lead to heart failure and complications for the pregnancy.
As a parent, learning your babies may have TRAP sequence can be frightening. But the Colorado Fetal Care Center (CFCC) is at the forefront of treatment and care for this condition.
Twin reversed arterial perfusion sequence, or TRAP sequence, occurs in twin pregnancies in which one of the babies does not fully form and has either a malformed or absent heart (acardiac twin). This then puts stress on the heart of the sibling twin, called the "pump" twin, because his or her heart is working for two.
In an acardiac twin pregnancy, the normal twin's heart must work harder in order to pump blood to not only the placenta, but also to the acardiac twin. This blood flow is the reverse of what occurs in a normal twin pregnancy, where oxygenated blood is provided by the placenta, with the baby returning unoxygenated blood to the placenta. In this condition, the acardiac twin adds an additional burden on the normal twin’s heart which may lead to heart failure.
The type of TRAP sequence babies have is determined by how developed the abnormal twin is. For example, he or she may have a very abnormal heart or no heart at all. Some have a partial formation of the upper body and head and others may have none. Additionally, each TRAP sequence needs to be evaluated to determine what risk it places on the normal twin.
TRAP sequence occurs in 1 in 35,000 pregnancies and in less than 1% of identical twin pregnancies. TRAP sequence is caused by the development of one abnormal twin in an identical twin set, or in what is called a monochorionic twin pregnancy. The normal twin then supplies the blood flow for the abnormal twin, which may lead to heart failure and death.
Because so much work is required for the healthy twin to pump blood to the acardiac twin, it leaves the healthy twin at risk for heart failure and death.
Other complications can include polyhydramnios (excess amniotic fluid), which can cause swelling for the mother, as well as preterm labor and delivery. This has been documented in 46% of all TRAP sequence twins.
TRAP sequence can be diagnosed through a routine ultrasound. Because they are identical twins that share a placenta, they need to be more closely monitored throughout gestation for a number of potential complications.
Indicators of TRAP sequence by ultrasound include:
Further examination of the blood flow between the twins can aid in the diagnosis of TRAP sequence.
Once TRAP sequence is diagnosed, it's critical that both the mother and babies are closely monitored to quickly catch complications that could put their health or lives at risk. At the Colorado Fetal Care Center, we select treatment options depending on the severity of the condition to improve outcomes for our tiniest patients.
The Colorado Fetal Care Center is one of the leading care centers for TRAP sequence in twin pregnancies and we have successfully treated more than 100 cases at our facility.
Treatment for TRAP sequence depends greatly on the severity of the impact on the normal twin. At the Colorado Fetal Care Center, we treat each patient as an individual and make recommendations based on what is best for that patient and his or her needs.
Treatment for TRAP sequence is needed only when there is risk to the normal twin's health. This risk is determined by how large the acardiac twin is in relation to the normal twin. In addition, we complete a thorough evaluation of how well the normal twin's heart is functioning. Treatment for TRAP sequence includes monitoring and possibly fetal intervention to save the life of the larger twin.
In the absence of any risk to the normal twin, we will recommend following the pregnancy closely by ultrasound. The ultrasound surveillance will ensure that the acardiac twin remains small and heart function of the normal twin remains strong throughout your pregnancy.
If the acardiac twin is large and there are signs of impending heart failure in the normal twin, we will recommend treatment. Treatment involves stopping blood flow to the acardiac twin to relieve the burden on the normal twin. This is accomplished by a procedure called radiofrequency ablation, or RFA. This procedure involves a small needle that is able to generate heat and is used to seal the blood vessels leading to the acardiac twin. In our experience, the "pump" twin survives 98% of the time following RFA for TRAP sequence.
In two-thirds of cases of twins with TRAP sequence, the pump and acardiac twins are in separate amniotic sacs. However, in one-third of cases, the babies share the same amniotic sac which may change the approach to treatment.
For twins found to be at risk of heart failure, there is a very high risk of losing the pregnancy. With treatment, however, survival is 98% and the average delivery occurs at 35 weeks. For those pregnancies that are at low risk for complications, outcomes are even better with term delivery expected.
Maternal-Fetal Medicine, Ob/Gyn Obstetrics & Gynecology